
Beijing
688621.SSBeijing Sun-Novo Pharmaceutical Research Co., Ltd. Price (688621.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
111,974,207
(0.023)%Description
Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of chemical drugs and peptide drugs in China. The company offers small molecule chemical generic drugs; peptide products; and drugs for indications, such as impetigo, acne, renal anemia, chronic kidney disease dialysis patient hyper parathyroid hormone, analgesia, and other symptoms. It also provides packaging material compatibility test, impurity research, extract research, migration research, safety evaluation, and other research ser... Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $28.9-65.83
- Market Cap 5.09B
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Drug Manufacturers - Specialty & Generic
- ceo: Mr. Yujing Liu
- IPO Date: June, 21, 2021
- Country: CN
- Currency: CNY
- Headquaters: No Data
- Employees: 1370
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
